Back to results
US 2010/0143322 A1Published application
Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
OwnerHans Uwe Wolf, Christoph Wilhelminventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of inhibitors of different N-methyl transferases in the therapy of Parkinson's syndrome, in particular idiopathic Parkinson's syndrome.
Claims14
A method for the treatment or prophylaxis treating of Parkinson's syndrome comprising inhibiting N-methyl transferases using at least of one exogenic or endogenic inhibitor of N-methyl transferases to prevent the formation of Parkinson's syndrome neurotoxins via methylation of non-methylated pre-neurotoxins.
Dependencies are inferred from the claim text.